Murat KOÇ, Nevra POLAT, Salih MOLLAHALİLOGLU, Hüseyin AYHAN

A SYSTEMATIC REVIEW OF EFFECTIVE BIOAGENT IN CHRONIC WOUNDS: THE MAGGOT BIOTHERAPY PYRAMID

Wound assessment is important in monitoring the effectiveness of treatment in chronic wounds. Therefore, a holistic approach is needed when evaluating effective wound treatment. Most chronic wounds require complementary treatment approaches and conventional treatments in modern medicine. This research was carried out by compiling studies on the past, present, and future of maggot (medical larvae) that cure nonhealing/hard-to-heal wounds; therapeutic larva types, therapy method, healing mechanism, wound healing effect with clinical studies, different usage areas and biological activities of the larvae and the metabolite components in the secretions that provide these activities. In conclusion, medical larvae applied with traditional and complementary medicine techniques to treat nonhealing, difficult-to-heal wounds have a wound-healing effect. However, more research is needed to identify the metabolite components in their secretions that provide their mechanism of action and biological activities.

PDF

___

1. Steenvoorde P, Jukema GN. The antimicrobial activity of maggots: in-vivo results. J Tissue Viability, 2004;14(3):97-101.
2. Wolff H, Hansson C. Larval therapy - an effective method of ulcer debridement. Clin Exp Dermatol 2003;28(2):134- 47.
3. Pechter E.A, Sherman R.A. Maggot Therapy: The Surgical Metamorphosis. Plastic Recon. Surgery, Oct. 1983;72(4):567-70
4. Mumcuoğlu K, Özkan AT. Supuratif Kronik Yaraların Maggot Debridman Tedavisi, Turkiye Parazitol Derg., 2009;33(4):307-15.
5. Whitaker IS, Twine C, Whitaker MJ, Welch M, Brown CS et al. Larval therapy from antiquity to the present day: mechanisms of action, clinical applications and future potential. Postgrad Med J, 2007; 83: 409-413.
6. Wayman J, Nirojogi V, Walker A, Sowinski A, Walker MA. The cost-effectiveness of larval therapy in venous ulcers. J Tissue Viability 2000;10(3):91-4.
7. Tanyuksel M, Araz E, Dundar K, et al. Maggot debridement therapy in treating chronic wounds in a military hospital set up in Turkey. Dermatology, 2005;210:115-8.
8. Tekin S, Polat E, Arslan A, et al. Larva debridman tedavisi: Klinik uygulamada ilk sonuçlar. II. Ulusal Yara Bakımı Kongresi.29 Kasım-01 Aralık, İstanbul. p.96. 2007.
9. Karaçam Z. Sistematik derleme metodolojisi: sistematik derleme hazırlamak için bir rehber. Dokuz Eylül Üniversitesi Hemşirelik Yüksekokulu Elektron. Derg 2013;6(1):26–33.
10. Moher D, Liberati A, Tetzlaff J, Altman DG; PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009 Jul 21;6(7):e1000097 (doi: 10.1371/journal.pmed.1000097).
11. CAPS. Critical Appraisal Skills Programme (Randomised Controlled Trial) Checklist. [Internet]. https://casp-uk.net/casp-tools-checklists/(Accessed: 3 February 2022)
12. Krajacic A. Consider Using Maggots. Today's Surgical Nurse, May-Jun. 1998;20(3):28-32.
13. Kingu H. J, Kuria S.K, Villet M.H. Cutaneous myiasis: Is Lucilia cuprina safe and acceptable for maggot debridement therapy, J. Cosm. Dermatol. Sci. Appl. 2012;2:79-82.
14. Unat E.K, Yücel A, Altaş K, Samastı M. İnsanın ökaryonlu parazitleri ve bunlarla oluşan hastalıkları, İstanbul Cerrahpaşa Tıp Fakültesi Vakfı Yayınları 1995;15:57-140.
15. Sherman R.A. Maggot therapy takes us back to the future of wound care: new and improved maggot therapy for the 21st century, J. Diabetes Sci Technol.2009;3:336–44.
16. Paul AG, Ahmad NW, Lee HL, et al. Maggot debridement therapy with Lucilia cuprina: a comparison with conventional debridement in diabetic foot ulcers. Int Wound J, 2009;6:39–46.
17. Blowfly Life Cycle Cleveland Museum of Natural History (reproduced with permission) [Internet] https://www.nlm.nih.gov/ visibleproofs/galleries/technologies/blowfly.html (Accessed: 3 February 2022).
18. Demirsoy A. Genel Zoocoğrafya ve Türkiye Zoocoğrafyası, Hayvan Coğrafyası, 2001; s.670.
19. Greenberg B, Kunıch J.C. Entomology and the Law: Flies as Forensic Indicators. First Ed., Cambridge University Press. Chapter 2. 2002.
20. Mumcuoglu KY, Clinical applications for maggots in wound care. Am J Clin Dermatol, 2001;2(4):219-27.
21. Moya-López J, Costela-Ruiz V, García-Recio E, Sherman RA, De Luna-Bertos E. Advantages of Maggot Debridement Therapy for Chronic Wounds: A Bibliographic Review. Adv Skin Wound Care. 2020 Oct;33(10):515-25 (doi: 10.1097/01.ASW.0000695776.26946.68. PMID: 32941225).
22. Jarczyk G, Jackowski M, Szpila K, Bozek G, Kapelaty S. Use of Lucilia sericata blowfly maggots in treating diabetic feet threatened with amputation. Acta Angiologica 2008;14(2)42–55.
23. Lerch K, Linde HJ, Lehn N, et al. Bacteria ingestion by blowfly larvae: an in vitro study. Dermatology; 2003;207(4):362.
24. Mumcuoglu KY, Ingber A, Gilead L, et al. Maggot therapy for the treatment of intractable wounds. Int J Dermatol. 1999;38(8):623-7 (doi:10.1046/j.1365-4362.1999.00770.x).
25. Özalp AH. Deneysel Nekrotizan Pankreatitte Maggot Terapi (Larva Debritman Tedavisi), Uzmanlık Tezi, Konya: Necmettin Erbakan Universitesi Meram Tıp Fakultesi Genel Cerrahi Anabilim Dalı, 2013.
26. Fleischmann W, Thoener B. Biobag - a live wound dressing containing maggots. Fifth International Conference on Biotherapy, Wurzburg, Germany, June 29-July 1, p. 8. 2000.
27. Tantawi T, Gohar Y, Kotb M, Beshara F, El-Naggar M. Clinical and microbiological efficacy of MDT in the treatment of diabetic foot ulcers. J Wound Care. 2007;16(9):379–83.
28. Biotherapy - History, Principles and Practice. In: Martin Grassberger, Ronald A. Sherman, Olga S. Gileva, Christopher M.H. Kim, Mumcuoglu KY, eds2013: https://link.springer.com/book/10.1007/978-94-007- 6585-6?noAccess=true
29. Bazalinski D, Wiech P, Szymanska P, Muster M, Kozka M. Application of Lucilia sericata Larvae in Debridement of Pressure Wounds in Outpatient Settings. J Vis Exp. 2021(178) (doi:10.3791/62590).
30. Nigam Y, Bexfield A, Thomas S, Ratcliffe NA. Maggot Therapy: The Science and Implication for CAM Part I – History and Bacterial Resistance. Evid-Based Compl Alt, 2006;3(2):223–7.
31. Sherman RA, Wyle F, Vulpe M. Maggot therapy for treatng pressure ulcers n spnal cord injury patents. J Spnal Cord Med. 1995;18(2):71–4.
32. Stoddard SR, Sherman RA, Mason BE, Pelsang DJ, Sherman RM. Maggot debridement therapy. An alternative treatment for nonhealing ulcers. Journal of the American Podiatric Medical Association. 1995;218–21.
33. Sherman R.A. Maggot versus conservative debridement therapy for the treatment of pressure ulcers. WoundRepair Regen. 2002;10:208–14
34. Sherman, R.A. Maggot Therapy for treating diabetic foot ulcers unresponsive to conventional therapy.Diabetes Care, 2003;26:446–51.
35. Markevich Y, McLeod-Roberts J, Mousley M, Melloy E. Maggot therapy for diabetic neuropathic foot wounds: a randomised study. In: 36th Annual Meeting of the European Association for the Study of Diabetes. 2000.
36. Mohd Zubir MZ, Holloway S, Mohd Noor N. Maggot Therapy in Wound Healing: A Systematic Review. Int J Environ Res Public Health. 2020 Aug 21;17(17):6103 (doi: 10.3390/ijerph17176103).
37. Marineau ML, Herrington MT, Swenor KM, Eron LJ. Maggot debridement therapy in the treatment of complex diabetic wounds. 2011, Hawaii Med J. 2009;70(6):121–4.
38. Opletalová K, Blaizot X, Mourgeon B, et al. Maggot therapy for wound debridement: A randomized multicentertrial. Arch. Derm. 2012;148:432–8.
39. Mudge E, Price P, Walkley N, Harding K.G. A randomised controlled trial of larval therapy for the debridement of leg ulcers: Results of a multicenter, randomised, controlled, open, observer-blind, parallel- group study.Wound Repair Regen. 2014;22:43–5.
40. Wang S yu, Wang J ning, Lv D cheng, Diao Y peng, Zhang Z. Clinical research on the bio-debridement effect of maggot therapy for treating chronically infected lesions. Orthop Surg. 2010;2(3):201–6.
41. Sherman RA, Shapiro CE, Yang RM. Maggot therapy for problematic wounds: uncommon and off-label applications. Adv Skin Wound Care, 2007b;20:602–10.
42. Grassberger M, Frank C. Initial Study of Arthropod Succession on Pig Carrion in a Central European Urban Habitat, Journal of Medical Entomology. 2004;41(3):511–23.
43. Greenberg B, Kunıch J.C. Entomology and the Law: Flies as Forensic Indicators. First Ed., Cambridge University Press. Chapter 2. 2002.
44. Gupta A. A review of the Use of Maggots in Wound Therapy; MS: Ann Plas Surg; 2008;60:224-7.
45. Huberman L, Gollop N, Mumcuoglu KY, Block C, Galun R. Antibacterial properties of whole-body extracts and haemolymph of Lucilia sericata maggots. J Wound Care; 2007;16(3):123-7.
46. Sirekbasan S, Polat E, Cangel U. The Effect of Bacterial Colonization and Maggot Debridement Treatment on Wound Healing in Chronic Venous Leg Ulcers. Clin Lab. 2021 May 1;67(5) (doi: 10.7754/Clin.Lab.2020.201137).
47. Yan L, Chu J, Li M, et al. Pharmacological Properties of the Medical Maggot: A Novel Therapy Overview. Evidence-Based Complementary and Alternative Medicine, 2018, pp.1-11.
48. Gazi U, Taylan-Ozkan A, Mumcuoglu KY. The effect of Lucilia sericata larval excretion/secretion (ES) products on cellular responses in wound healing. Med Vet Entomol. 2021 Sep;35(3):257-66 (doi: 10.1111/mve.12497).
49. Cerovsky V, Slaninova J, Fucik V, et al. Lucifensin, a novel insect defensin of medicinal maggots: synthesis and structural study. Chembiochem 2011;12: 1352–61.
50. Calendar G, Pritchard D, Nigam Y, Jung W, Nibbering P. Multiple actions of Lucilia sericata larvae in hard- to-heal wounds. Bio Essays. 2013;35(12):1083-92.
51. Polat E, Cakan H, Aslan M. Detection of the anti-leishmanial effect of the Lucilia sericata larval secretions in vitro and in vivo on Leishmania tropica: First work. Experimental Parasitology. 2012;132(2):129-34.
52. Zhang W, Jiang W, Lan XJGmj. Exploration of the antitumor effects and mechanisms of Chrysomya megacephala extracts in H22 hepatomabearing mice. 2017;39(2):215-9.
53. Nigam Y. Morgan C. Does maggot therapy promote wound healing? The clinical and cellular evidence. Journal of the European Academy of Dermatology and Venereology, 2016;30:776–82.
54. Bazalinski D. Efficacy of Biological Therapy using Lucilia sericata Larvae in the Treatment of Chronic Wounds in Patients in Long-Term and Palliative Care. Uniwersytet Rzeszowski: Rzeszów, Poland. 2019.
55. Tourle R, Downie D.A. Villet, M.H. Flies in the ointment: A morphological and molecular comparison of Lucilia cuprina and Lucilia sericata (Diptera: Calliphoridae) in South Africa. Med. Vet. Entomol. 2009;23:6– 14.
56. Tombulturk FK, Kanigur-Sultuybek G. A molecular approach to maggot debridement therapy with Lucilia sericata and its excretions/secretions in wound healing. Wound Repair Regen. 2021 Nov;29(6):1051-61. (doi: 10.1111/wrr.12961).
57. Sun X, Jiang K, Chen J, et al. A systematic review of maggot debridement therapy for chronically infected wounds and ulcers.International Journal of Infectious Diseases, 2014;25:32–7.
58. Cazander G, van Veen KE, Bouwman LH, Bernards AT, Jukema GN. The influence of maggot excretions on PAO1 biofilm formation on different biomaterials. Clin Orthop Relat Res 2009;467:536-45.
59. Barnes KM, Dixon RA, Gennard DEJJomm. The antibacterial potency of the medicinal maggot, Lucilia sericata (Meigen): variation in laboratory evaluation. 2010;82(3):234-7
60. Nigam Y, Dudley E, Bexfield A, et al. The physiology of wound healing by the medicinal Maggot, Lucilia sericata. Adv Insect Physiol 2010;39:39–81.